drugset / Trial / NCT01260025
Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor
NaSingle-groupOpen-labelTreatment
Summary
1. MTD and DLT of M2ES 2. Pharmacokinetics of M2ES
Timeline
- Start
- 2009-09
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEDylated Recombinant Human Endostatin | Unknown | 7.5 mg/m2 | — |